Don B. Sanders, MD, MS

Associate Professor of Pediatrics
Indiana University School of Medicine

Poster(s):

• (25) Impact of repeated non-treatment on long-term lung function
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (118) Antibiotic Regimen Changes During Pediatric Pulmonary Exacerbation Treatment
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (128) Sex-based differences in cystic fibrosis pulmonary exacerbations: Sub-analysis of the STOP2 cohort
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (142) The STOP PEDS Pilot Study of Oral Antibiotic Timing in Pediatric CF Pulmonary Exacerbations
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (176) How frequently should the lung clearance index be measured in children with cystic fibrosis?
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (202) Clinical Characteristics of Children with Cystic Fibrosis Who Receive Gastrostomy Tubes
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (217) Benefits of Gastrostomy Tube Placement on Clinical Outcomes in Children with Cystic Fibrosis
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (349) Respiratory Therapy Educational Assessment Tool Implementation in a Pediatric Cystic Fibrosis Center
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET

• (510) Prevalence and Clinical Impact of Respiratory Viral Infections in the STOP2 Study of Cystic Fibrosis Pulmonary Exacerbations
  Thursday, November 3, 2022

  12:00 PM – 12:40 PM ET

• (541) Effect of therapeutic antibiotic exposure on the oropharyngeal and fecal microbiota in infants with cystic fibrosis
  Thursday, November 3, 2022

  12:45 PM – 1:25 PM ET